Results 231 to 240 of about 321,951 (345)

Plastid and nuclear phylogenomics of Cyphostemma (Vitaceae) provide new insights into genome size evolution across sub‐Saharan Africa

open access: yesJournal of Integrative Plant Biology, EarlyView.
Some African Cyphostemma species evolved much larger genomes as they adapted to dry, rocky habitats. These expansions are linked to succulent traits and specialization on nutrient‐rich limestone outcrops. The findings show how climate‐driven aridification shaped plant evolution and highlight broader genome‐environment patterns across flowering plants ...
Rindra M. Ranaivoson   +18 more
wiley   +1 more source

Allgemeine Biologie

open access: hybrid, 1915
Carl Chun, Erwin Baur, W. Johannsen
openalex   +2 more sources

Scaling of internal joint distance in the elbow of small‐ to medium‐sized mammals: Implications for range of motion analyses

open access: yesJournal of Anatomy, EarlyView.
We investigated the internal joint distances (IJDs) of the humero‐ulnar and humero‐radial joint, within a sample of 15 small‐ to medium‐sized mammals and report isometric results. We also found that joint poses had no effect on IJDs and that IJDs scale isometrically within small species.
Adrian Scheidt   +2 more
wiley   +1 more source

Pediatric Hepatobiliary Lithiasis in Homozygous Sickle Cell Disease: Laboratory Insights Into Cholestasis and Hemolysis. [PDF]

open access: yesCureus
Rakotonjafiniarivo FH   +4 more
europepmc   +1 more source

Increased intervals in enzyme replacement therapy for stable type 1 Gaucher disease: A non‐inferiority sequential trial emulation

open access: yesJournal of Internal Medicine, EarlyView.
Abstract Objective To compare the efficacy and safety of extended interval (Q3–4W) enzyme replacement therapy (ERT) versus standard biweekly (Q2W) ERT in clinically stable type 1 Gaucher disease (GD) patients. Methods We emulated a target trial with a sequential trial design, using data from the French Gaucher Disease Registry.
Maxime Beydon   +31 more
wiley   +1 more source

DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer. [PDF]

open access: yesMol Ther
Le TK   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy